These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 16434341)

  • 21. Atypical neuroleptic malignant syndrome in a young male precipitated by oral sodium valproate.
    Menon V; Rajkumar RP; Thamizh JS; Selvakumar N
    Aust N Z J Psychiatry; 2016 Dec; 50(12):1208-1209. PubMed ID: 27207860
    [No Abstract]   [Full Text] [Related]  

  • 22. Ammonia induced encephalopathy from valproic acid in a bipolar patient: case report.
    Elgudin L; Hall Y; Schubert D
    Int J Psychiatry Med; 2003; 33(1):91-6. PubMed ID: 12906346
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancytopenia and valproic acid: a dose-related association.
    Oluboka OJ; Haslam D; Gardner DM
    J Am Geriatr Soc; 2000 Mar; 48(3):349-50. PubMed ID: 10733073
    [No Abstract]   [Full Text] [Related]  

  • 24. Acute Pancreatitis Associated with Valproate Treatment.
    Quan W; Shao Q; Zhang H; Liu FH; Zhang XH
    Chin Med J (Engl); 2018 Aug; 131(15):1889-1890. PubMed ID: 30058594
    [No Abstract]   [Full Text] [Related]  

  • 25. Carbamazepine and valproate for the treatment of bipolar disorder: a review of the literature.
    Nasrallah HA; Ketter TA; Kalali AH
    J Affect Disord; 2006 Oct; 95(1-3):69-78. PubMed ID: 16780960
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A critical interaction between ertapenem and valproic acid.
    Molnar GP; Stephens KJ; George LV; Stewart JT
    J Clin Psychopharmacol; 2015 Jun; 35(3):348-50. PubMed ID: 25871574
    [No Abstract]   [Full Text] [Related]  

  • 27. Extracorporeal management of valproic acid toxicity: a case report and review of the literature.
    Al Aly Z; Yalamanchili P; Gonzalez E
    Semin Dial; 2005; 18(1):62-6. PubMed ID: 15663767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modafinil treatment of excessive sedation associated with divalproex sodium.
    Berigan T
    Can J Psychiatry; 2004 Jan; 49(1):72-3. PubMed ID: 14763681
    [No Abstract]   [Full Text] [Related]  

  • 29. Valproate-associated hyperammonemic encephalopathy.
    Wadzinski J; Franks R; Roane D; Bayard M
    J Am Board Fam Med; 2007; 20(5):499-502. PubMed ID: 17823470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study.
    Gau SS; Chao PF; Lin YJ; Chang CJ; Gau CS
    J Clin Psychopharmacol; 2008 Oct; 28(5):509-17. PubMed ID: 18794645
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate.
    Senturk V; Goker C; Bilgic A; Olmez S; Tugcu H; Oncu B; Atbasoglu EC
    Bipolar Disord; 2007 Jun; 9 Suppl 1():136-44. PubMed ID: 17543032
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatotoxicity with combination of valproic acid, ritonavir, and nevirapine: a case report.
    Cozza KL; Swanton EJ; Humphreys CW
    Psychosomatics; 2000; 41(5):452-3. PubMed ID: 11015639
    [No Abstract]   [Full Text] [Related]  

  • 33. Low-Dose Valproate-Related Peripheral Edema in Patients With Bipolar Disorder: Two Case Reports.
    Maneerot T; Jenraumjit R; Kijsawatpaiboon S; Reungyos J
    J Clin Psychopharmacol; 2019; 39(4):412-413. PubMed ID: 31188235
    [No Abstract]   [Full Text] [Related]  

  • 34. Toxic effects of nefazodone.
    Brazelton T; Blanc PD; Olson KR
    Ann Emerg Med; 1997 Oct; 30(4):550-1. PubMed ID: 9326873
    [No Abstract]   [Full Text] [Related]  

  • 35. Valproate is associated with new-onset oligoamenorrhea with hyperandrogenism in women with bipolar disorder.
    Joffe H; Cohen LS; Suppes T; McLaughlin WL; Lavori P; Adams JM; Hwang CH; Hall JE; Sachs GS
    Biol Psychiatry; 2006 Jun; 59(11):1078-86. PubMed ID: 16448626
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Severe Cognitive Impairment Associated With a High Free But Therapeutic Total Concentration of Valproic Acid Due to Hypoalbuminemia in an Older Patient With Bipolar Disorder.
    Dautzenberg G; Nederlof M; Beekman A; Egberts T; Heerdink ER
    J Clin Psychopharmacol; 2018 Jun; 38(3):265-268. PubMed ID: 29621091
    [No Abstract]   [Full Text] [Related]  

  • 37. [Valproic acid in prophylaxis of bipolar disorder. A case of valproate-induced encephalopathy].
    Rottach KG; Weiss-Brummer J; Wieland U; Schmauss M
    Nervenarzt; 2000 May; 71(5):401-3. PubMed ID: 10846716
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Open-label steady-state pharmacokinetic drug interaction study on co-administered quetiapine fumarate and divalproex sodium in patients with schizophrenia, schizoaffective disorder, or bipolar disorder.
    Winter HR; DeVane CL; Figueroa C; Ennis DJ; Hamer-Maansson JE; Davis PC; Smith MA
    Hum Psychopharmacol; 2007 Oct; 22(7):469-76. PubMed ID: 17729385
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Valproic acid-induced myopathy in a patient with schizoaffective disorder.
    Reiche I; Tröger U; Postel SC; Wolf R; Bode-Böger SM
    J Clin Psychopharmacol; 2009 Aug; 29(4):402-3. PubMed ID: 19593189
    [No Abstract]   [Full Text] [Related]  

  • 40. Case of significantly delayed divalproex-induced thrombocytopaenia.
    Park A; Shapiro B; Hedayati B; Faziola L
    BMJ Case Rep; 2019 Dec; 12(12):. PubMed ID: 31796434
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.